|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/05/15 Unitedhealth Group Inc 10-Q 9/30/15 84:13M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 867K
2: EX-10.2 Material Contract HTML 40K
3: EX-10.3 Material Contract HTML 31K
4: EX-10.4 Material Contract HTML 75K
5: EX-10.5 Material Contract HTML 77K
6: EX-10.6 Material Contract HTML 75K
7: EX-12.1 Statement re: Computation of Ratios HTML 35K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 40K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 29K
56: R1 Document and Entity Information Document HTML 43K
44: R2 Condensed Consolidated Balance Sheets HTML 129K
54: R3 Condensed Consolidated Balance Sheet HTML 44K
(Parenthetical)
58: R4 Condensed Consolidated Statements of Operations HTML 101K
78: R5 Condensed Consolidated Statements of Comprehensive HTML 66K
Income
46: R6 Condesned Consolidated Statements of Changes in HTML 90K
Equity
53: R7 Condensed Consolidated Statements of Cash Flows HTML 118K
40: R8 Basis of Presentation (Notes) HTML 34K
31: R9 Business Combination (Notes) HTML 52K
79: R10 Goodwill and Other Intangible Assets (Notes) HTML 64K
60: R11 Investments (Notes) HTML 255K
59: R12 Fair Value (Notes) HTML 336K
65: R13 Medicare Part D Pharmacy Benefits (Notes) HTML 42K
66: R14 Medical Costs Reserve Development (Notes) HTML 38K
63: R15 Health Insurance Industry Tax (Notes) HTML 28K
67: R16 Commercial Paper and Long-Term Debt (Notes) HTML 240K
55: R17 Shareholders' Equity (Notes) HTML 43K
57: R18 Share-Based Compensation (Notes) HTML 109K
62: R19 Commitments and Contingencies (Notes) HTML 39K
84: R20 Segment Financial Information (Notes) HTML 326K
74: R21 Basis of Presentation (Policies) HTML 37K
50: R22 Goodwill and Other Intangible Assets Goodwill and HTML 28K
Other Intangible Assets (Policies)
61: R23 Business Combination (Tables) HTML 44K
52: R24 Goodwill and Other Intangible Assets (Tables) HTML 66K
24: R25 Investments (Tables) HTML 256K
75: R26 Fair Value (Tables) HTML 339K
81: R27 Medicare Part D Pharmacy Benefits (Tables) HTML 39K
35: R28 Medical Costs Reserve Development (Tables) HTML 36K
34: R29 Commercial Paper and Long-Term Debt (Tables) HTML 241K
38: R30 Shareholders' Equity (Tables) HTML 32K
39: R31 Share-Based Compensation (Tables) HTML 112K
41: R32 Segment Financial Information (Tables) HTML 321K
22: R33 Business Combination (Details) HTML 60K
71: R34 Business Combination Acquired Assets and HTML 43K
Liabilities (Details)
48: R35 Business Combination Acquired finite-lived HTML 35K
intangible assets (Details)
51: R36 Goodwill and Other Intangible Assets Goodwill HTML 44K
Rollforward (Details)
27: R37 Goodwill and Other Intangible Assets Future HTML 35K
Amortization Expense relating to Intangible Assets
(Details)
83: R38 Investments (Narrative) (Details) HTML 28K
16: R39 Investments (Short-Term and Long-Term Investments) HTML 92K
(Details)
42: R40 Investments (Amortized Cost and Fair Value of HTML 71K
Available-for-Sale Debt Securities by Contractual
Maturity) (Details)
77: R41 Investments (Amortized Cost and Fair Value of HTML 57K
Held-To-Maturity Debt Securities by Contractual
Maturity) (Details)
26: R42 Investments (Fair Value of Available-For-Sale HTML 69K
Investments with Gross Unrealized Losses by
Investment Type and Length of Time That Individual
Securities Have Been in a Continuous Unrealized
Loss Position) (Details)
33: R43 Investments (Net Realized Gains) (Details) HTML 51K
37: R44 Fair Value (Narrative) (Details) HTML 50K
45: R45 Fair Value (Financial Assets and Liabilities, HTML 92K
Excluding AARP, Measured at Fair Value on a
Recurring Basis) (Details)
21: R46 Fair Value (Financial Assets and Liabilities, HTML 86K
Excluding AARP, Not Measured at Fair Value on a
Recurring Basis) (Details)
30: R47 Fair Value (Reconciliation of Assets Measured at HTML 50K
Fair Value on a Recurring Basis Using Level 3
Inputs) (Details)
18: R48 Fair Value Fair Value Inputs Assets Quantitative HTML 45K
Information (Details)
76: R49 Fair Value (Assets and Liabilities measured at HTML 108K
fair value on a recurring basis) (Details)
25: R50 Medicare Part D Pharmacy Benefits Schedule of HTML 33K
Receivables and Payables (Details)
73: R51 Medical Costs Reserve Development (Details) HTML 29K
28: R52 Health Insurance Industry Tax (Details) HTML 29K
43: R53 Commercial Paper and Long-Term Debt (Narrative) HTML 73K
(Details)
17: R54 Commercial Paper and Long-Term Debt (Details) HTML 179K
20: R55 Commercial Paper and Long-Term Debt Fair Value HTML 38K
Hedges Statement of Financial Position Location
(Details)
36: R56 Commercial Paper and Long-Term Debt Fair Value HTML 38K
Hedges Effect of Changes in Fair Value Hedges on
Income (Details)
23: R57 Shareholders' Equity (Details) HTML 35K
80: R58 Shareholders' Equity Dividends Paid (Details) HTML 30K
47: R59 Share-based Compensation Narrative (Details) HTML 30K
64: R60 Share-Based Compensation (Stock Option and SAR HTML 72K
Activity) (Details)
29: R61 Share-Based Compensation (Restricted Share HTML 43K
Activity) (Details)
32: R62 Share-Based Compensation Other Share-Based HTML 53K
Compensation Data (Details)
70: R63 Share-Based Compensation (Share-Based Compensation HTML 46K
Principal Fair Value Assumptions) (Details)
68: R64 Commitments and Contingencies (Details) HTML 40K
49: R65 Segment Financial Information (Narrative) HTML 32K
(Details)
69: R66 Segment Financial Information (Details) HTML 114K
82: XML IDEA XML File -- Filing Summary XML 149K
19: EXCEL IDEA Workbook of Financial Reports XLSX 91K
10: EX-101.INS XBRL Instance -- unh-20150930 XML 5.30M
12: EX-101.CAL XBRL Calculations -- unh-20150930_cal XML 240K
13: EX-101.DEF XBRL Definitions -- unh-20150930_def XML 1.07M
14: EX-101.LAB XBRL Labels -- unh-20150930_lab XML 1.88M
15: EX-101.PRE XBRL Presentations -- unh-20150930_pre XML 1.23M
11: EX-101.SCH XBRL Schema -- unh-20150930 XSD 184K
72: ZIP XBRL Zipped Folder -- 0000731766-15-000049-xbrl Zip 316K
| Exhibit |
Three Months Ended September 30, | Nine
Months Ended September 30, | |||||||||||||||
(dollars in millions) | 2015 | 2014 | 2015 | 2014 | ||||||||||||
Earnings before income taxes | $ | 2,789 | $ | 2,751 | $ | 8,023 | $ | 7,042 | ||||||||
Fixed
charges | 272 | 186 | 653 | 566 | ||||||||||||
Total earnings available for fixed charges | $ | 3,061 | $ | 2,937 | $ | 8,676 | $ | 7,608 | ||||||||
Fixed
Charges: | ||||||||||||||||
Interest expense | $ | 229 | $ | 152 | $ | 530 | $ | 467 | ||||||||
Interest
component of rental payments | 43 | 34 | 123 | 99 | ||||||||||||
Total fixed charges | $ | 272 | $ | 186 | $ | 653 | $ | 566 | ||||||||
Ratio
of earnings to fixed charges | 11.3 | 15.8 | 13.3 | 13.4 | ||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 UnitedHealth Group Inc. 10-K 12/31/23 119:19M 2/24/23 UnitedHealth Group Inc. 10-K 12/31/22 119:19M 2/15/22 UnitedHealth Group Inc. 10-K 12/31/21 113:19M 3/01/21 UnitedHealth Group Inc. 10-K 12/31/20 107:17M |